105 related articles for article (PubMed ID: 2006035)
1. [Arterial hypertension and hyporeninemic hypoaldosteronism. Description of a clinical case].
Torboli P; Spagnolli W; Contu C; Ramponi C; Marzano A; Fedrizzi A; Miori R
Minerva Med; 1991 Mar; 82(3):147-50. PubMed ID: 2006035
[TBL] [Abstract][Full Text] [Related]
2. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
Foresti V; Parisio E; Ricci G
Minerva Med; 1987 Sep; 78(17):1305-11. PubMed ID: 2444906
[TBL] [Abstract][Full Text] [Related]
3. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
[TBL] [Abstract][Full Text] [Related]
4. Factitious hypertension with mineralocorticoid excess in an infant.
De Stefano P; Bongo IG; Borgna-Pignatti C; Severi F
Helv Paediatr Acta; 1983 May; 38(2):185-9. PubMed ID: 6874387
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis, oedema and arterial hypertension: different syndromes related to topical use of 9-alpha-fluoroprednisolone.
Lauzurica R; Bonal J; Bonet J; Romero R; Teixido J; Serra A; Caralps A
J Hum Hypertens; 1988 Oct; 2(3):183-6. PubMed ID: 3236321
[TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension induced by an excess of mineralocorticoids caused by abuse of nasal spray. Report of a case].
De Venuto G; Mattarei M; Dal Piaz A; De Santa A; Torboli PL; Miori R
Minerva Med; 1984 Jun; 75(27):1673-77. PubMed ID: 6205328
[TBL] [Abstract][Full Text] [Related]
7. Severe hyperkalaemia due to mefenamic acid-induced hyporeninaemic hypoaldosteronism.
Chan JC; Chan TY; Ko TC; Chow CC; Critchley JA
Br J Clin Pract; 1995; 49(3):161-2. PubMed ID: 7779674
[TBL] [Abstract][Full Text] [Related]
8. An unusual case of iatrogenic hypertension.
Limone P; Porta M; Isaia GC
Minerva Endocrinol; 1985; 10(1):31. PubMed ID: 3903464
[No Abstract] [Full Text] [Related]
9. [Again on the subject of arterial hypertension caused by the chronic cutaneous application of mineralocorticoids].
Bisignani G; Boncompagni F; Plastina F
Minerva Endocrinol; 1988; 13(1):16. PubMed ID: 3367885
[No Abstract] [Full Text] [Related]
10. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments].
Arnal JM; Moneo MI; Loris C
An Esp Pediatr; 1987 Jan; 26(1):65-6. PubMed ID: 3826948
[No Abstract] [Full Text] [Related]
11. [Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone].
Virgolini L; Geatti O; Giunta G
Minerva Cardioangiol; 1984; 32(7-8):473-5. PubMed ID: 6208510
[No Abstract] [Full Text] [Related]
12. Pseudohyperaldosteronism due to application of an antihemorrhoid cream.
Marin F; González Quintela A; Moya M; Suárez E; de Zárraga M
Nephron; 1989; 52(3):281-2. PubMed ID: 2739869
[TBL] [Abstract][Full Text] [Related]
13. [Hypokalemic myopathy in arterial hypertension].
Santeusanio F; Nunzi E; Natali P; Nicoletti I; Angeletti G; Filipponi P; Rambotti P
Minerva Med; 1982 Sep; 73(35):2279-86. PubMed ID: 7110606
[TBL] [Abstract][Full Text] [Related]
14. Severe hypertension in childhood due to prolonged skin application of a mineralocorticoid ointment.
Bartorelli A; Rimondini A
Hypertension; 1984; 6(4):586-8. PubMed ID: 6746088
[TBL] [Abstract][Full Text] [Related]
15. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)].
Vasconez F; Pérez-Garcia R; Olivas E; Bolívar JE; Valderrábano F
Med Clin (Barc); 1980 Dec; 75(10):430-4. PubMed ID: 7464329
[TBL] [Abstract][Full Text] [Related]
16. [A case of secondary hypoaldosteronism during the treatment of arterial hypertension with propranolol].
Ciechanowski K; Marzecka J
Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):597. PubMed ID: 1488336
[No Abstract] [Full Text] [Related]
17. [Exogenous mineralocorticoid hypertension: pathogenetic and clinical considerations].
Armanini D
G Clin Med; 1990; 71(8-9):483-92. PubMed ID: 2279623
[No Abstract] [Full Text] [Related]
18. [Hypermineralocorticism secondary to the topical use of corticoids].
Rama H; Carreras L; Martínez-Amenos A; Sarrias X
Rev Clin Esp; 1984 Aug 15-31; 174(3-4):111-4. PubMed ID: 6515071
[No Abstract] [Full Text] [Related]
19. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].
Cantello R; Bergamini L; Delsedime M; Durelli L; Troni W; Gilli M; Cocito D
Minerva Med; 1983 Jun; 74(25):1463-7. PubMed ID: 6856155
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
Mantero F; Armanini D; Opocher G; Fallo F; Sampieri L; Cuspidi B; Ambrosi C; Faglia G
Am J Med; 1981 Sep; 71(3):352-7. PubMed ID: 6169277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
